Biodegradable metallo-elastomer
Biodegradable elastomers are useful in many biomedical applications. Elastomers are crosslinked network
polymers. The crosslinks can be made of covalent bonds or weak bonds such as a physical bond. The former
produces thermosets, which usually have high elasticity but cannot be processed after crosslinking. The latter
produces thermoplastics, which usually have lower elasticity but are easier to process. Metal coordination bond
has medium bond strength in between covalent bonds and weak physical bonds. We will invent a series of
biodegradable metallo-elastomers where the crosslink is formed by metal coordination bonds. An advantage of
this approach is that one polymeric ligand can bind many different metal ions, thereby producing variant
elastomers, each with unique properties. Furthermore, metal ions have inherent bioactivities, an area
underexplored in biomaterials. Our preliminary study demonstrates that the materials can be highly elastic;
matching or exceeding the elasticity of elastomers crosslinked by covalent bonds. Furthermore, the resultant
elastomers contain very small amounts of metal ions and exhibit no noticeable toxicity. On the contrary, they are
more biocompatible than polycaprolactone (PCL), used in many FDA-approved medical implants.
Many transition metal ions have inherent bioactivity. Enzymes further enhance and specify these activities by
providing amino acid ligands and binding pockets. Copper ion (Cu2+) is one of the first angiogenic factors
discovered and is known to upregulate angiogenic growth factors. In redox enzymes such as superoxide
dismutase, Cu2+ provides the critical redox activity to break down the superoxide radical. This research will
elucidate the structure-function relationship of metallo-elastomers in two specific aims: the first will explore the
pro-angiogenic properties of Cu2+, the second will study the anti-ROS activities of Cu2+. Taking advantage of the
elasticity of these polymers, we will test the polymers created in this proposal in models of skin wound healing.
Aim 1 will investigate the angiogenic properties of Cu metallo-elastomers and their potential in improving the
survival of skin flaps. Aim 2 will investigate the capability of Cu metallo-elastomer to decompose reactive oxygen
species using a polymer bearing basic resemblance to the active site of superoxide dismutase. These materials
will potentially increase the integration of skin grafts.
Upon completion of this project, we expect to have built a basic framework on how metallo-elastomers interact
with biological systems. We will better understand how altering the basic structure of the elastomer will impact
its function. Furthermore, we will appreciate the effectiveness of these elastomers in increasing the survival and
integration of skin grafts and skin flaps. The knowledge gained will fundamentally impact biomaterial design and
practically impact host integration of medical implants.
Public Health Relevance Statement
Medical implants will benefit from materials with inherent ability to promote angiogenesis and reduce oxidative
stress associated with inflammation caused by the surgery and the presence of a foreign body. We will invent a
series of biodegradable metallo-elastomers that can mimic the activity of metalloenzymes to achieve
angiogenesis and anti-inflammation.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
01-September-2022
Project End Date
31-May-2026
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$365,102
Direct Costs
$285,087
Indirect Costs
$80,015
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$365,102
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB032450-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB032450-03
Patents
No Patents information available for 5R01EB032450-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB032450-03
Clinical Studies
No Clinical Studies information available for 5R01EB032450-03
News and More
Related News Releases
No news release information available for 5R01EB032450-03
History
No Historical information available for 5R01EB032450-03
Similar Projects
No Similar Projects information available for 5R01EB032450-03